Peter Archibald

Peter Archibald serves as the Process Development Manager for Upstream at Rentschler Biopharma SE, where responsibilities include leading the viral vector upstream process development team and managing USP scientists, alongside serving as the Biosafety Officer for the Stevenage site. Previously, Peter held various leadership positions at GSK from November 2015 to May 2023, culminating in the role of Scientific Leader for the Upstream Vector Process Development team in the Cell & Gene Therapy department. Key achievements include overseeing vector CMC activities, process development, tech transfers, and regulatory submissions. Peter's academic background features a Ph.D. in Regenerative Medicine from Loughborough University, where research focused on automated and manual cell culture processes involving various stem cells.